A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
Bacterial corneal ulcers are a leading cause of pediatric blindness in underdeveloped
countries due to a lack of antibiotic availability and affordability, among other reasons.
Povidone-iodine, an inexpensive and readily available broad-spectrum antimicrobial agent, may
be an effective and affordable treatment for corneal ulcers, allowing preservation of sight
for those afflicted with this disease.
Phase:
Phase 2
Details
Lead Sponsor:
Los Angeles Biomedical Research Institute Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Collaborators:
Joseph Eye Hospital Kolokotrones Family Foundation L.V. Prasad Eye Institute Research to Prevent Blindness Thrasher Research Fund University of California, Los Angeles University of the Philippines